James Turnbull

1.1k total citations · 1 hit paper
27 papers, 870 citations indexed

About

James Turnbull is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, James Turnbull has authored 27 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in James Turnbull's work include Prostate Cancer Treatment and Research (9 papers), Renal cell carcinoma treatment (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). James Turnbull is often cited by papers focused on Prostate Cancer Treatment and Research (9 papers), Renal cell carcinoma treatment (4 papers) and Prostate Cancer Diagnosis and Treatment (4 papers). James Turnbull collaborates with scholars based in United States, United Kingdom and France. James Turnbull's co-authors include Andrew J. Armstrong, Daniel J. George, Rhonda L. Bitting, Matthew S. Marengo, Christina I. Herold, Mariano A. García-Blanco, Gabor Kemeny, P. Kelly Marcom, Sebastian Oltean and Evert Nieboer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Radiology.

In The Last Decade

James Turnbull

26 papers receiving 848 citations

Hit Papers

Circulating Tumor Cells f... 2011 2026 2016 2021 2011 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers
    2011 536 citations Andrew J. Armstrong, Matthew S. Marengo et al. Molecular Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Turnbull United States 10 517 313 312 265 111 27 870
Joan Bolt‐de Vries Netherlands 20 591 1.1× 598 1.9× 405 1.3× 508 1.9× 100 0.9× 34 1.4k
Zhangjun Cheng China 20 296 0.6× 474 1.5× 245 0.8× 560 2.1× 63 0.6× 65 1.4k
Daniel C. Christoph Germany 19 579 1.1× 248 0.8× 617 2.0× 498 1.9× 30 0.3× 81 1.3k
Hongjun Gao China 19 557 1.1× 348 1.1× 449 1.4× 478 1.8× 107 1.0× 72 1.1k
Kara Hamilton United States 10 206 0.4× 354 1.1× 200 0.6× 371 1.4× 31 0.3× 14 945
Sun Young Lee South Korea 15 331 0.6× 320 1.0× 121 0.4× 236 0.9× 238 2.1× 55 912
Carla Cavaliere Italy 20 280 0.5× 252 0.8× 368 1.2× 353 1.3× 21 0.2× 52 952
Jeremy McGuire United States 10 188 0.4× 257 0.8× 111 0.4× 320 1.2× 46 0.4× 20 740
R E Durand Canada 11 260 0.5× 298 1.0× 146 0.5× 239 0.9× 130 1.2× 15 696
Yongfu Ma China 18 150 0.3× 475 1.5× 193 0.6× 550 2.1× 104 0.9× 44 945

Countries citing papers authored by James Turnbull

Since Specialization
Citations

This map shows the geographic impact of James Turnbull's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Turnbull with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Turnbull more than expected).

Fields of papers citing papers by James Turnbull

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Turnbull. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Turnbull. The network helps show where James Turnbull may publish in the future.

Co-authorship network of co-authors of James Turnbull

This figure shows the co-authorship network connecting the top 25 collaborators of James Turnbull. A scholar is included among the top collaborators of James Turnbull based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Turnbull. James Turnbull is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freedland, Stephen J., John P. Mulhall, Martin Gleave, et al.. (2025). Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study. European Urology. 87(5). 507–511. 4 indexed citations
2.
Schiffmann, Raphael, James Turnbull, Ruth Pulikottil-Jacob, et al.. (2025). Gaucher disease type 3 from infancy through adulthood: a conceptual model of signs, symptoms, and impacts associated with ataxia and cognitive impairment. Orphanet Journal of Rare Diseases. 20(1). 171–171. 1 indexed citations
3.
Simmons, Kimber M., Stephen E. Gitelman, Robert Hill, et al.. (2025). Real‐world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes. Diabetes Obesity and Metabolism. 27(5). 2495–2506. 2 indexed citations
4.
5.
Schiffmann, Raphael, Eugen Mengel, Mary Wallace, et al.. (2024). Qualitative Study of the Patient Experience with Venglustat for Gaucher Disease Type 3 in a Phase 2 Open-Label, Multicenter, Multinational Study (LEAP). Advances in Therapy. 41(7). 2907–2923. 7 indexed citations
6.
Yu, Jingbo, Nandita Khera, James Turnbull, et al.. (2023). Impact of Chronic Graft-versus-Host Disease on Patient Employment, Income, and Informal Caregiver Burden: Findings From the Living With Chronic GVHD Patient Survey. Transplantation and Cellular Therapy. 29(7). 470.e1–470.e9. 6 indexed citations
7.
Cella, David, Arijit Ganguli, James Turnbull, Jeffrey M. Rohay, & Robert Morlock. (2022). US Population Reference Values for Health-Related Quality of Life Questionnaires Based on Demographics of Patients with Prostate Cancer. Advances in Therapy. 39(8). 3696–3710. 1 indexed citations
8.
Reaney, Matthew, et al.. (2022). Development of an Item Bank to Assess Patient-Reported Outcomes: Signs, Symptoms, and Impacts of COVID-19. Patient. 15(6). 703–713. 1 indexed citations
9.
10.
11.
Kanesvaran, Ravindran, et al.. (2014). A Single-Arm Phase 1b Study of Everolimus and Sunitinib in Patients With Advanced Renal Cell Carcinoma. Clinical Genitourinary Cancer. 13(4). 319–327. 12 indexed citations
12.
Bitting, Rhonda L., Patrick Healy, Patricia Creel, et al.. (2013). A Phase Ib Study of Combined VEGFR and mTOR Inhibition With Vatalanib and Everolimus in Patients With Advanced Renal Cell Carcinoma. Clinical Genitourinary Cancer. 12(4). 241–250. 24 indexed citations
13.
Pal, Sumanta K., Lee Stern, John Coombs, et al.. (2013). Real-world treatment patterns in third-line patients with metastatic renal cell carcinoma (mRCC): The changing landscape in the United States.. Journal of Clinical Oncology. 31(6_suppl). 390–390. 5 indexed citations
14.
Spritzer, Charles E., P. Diana Afonso, Emily N. Vinson, et al.. (2013). Bone Marrow Biopsy: RNA Isolation with Expression Profiling in Men with Metastatic Castration-resistant Prostate Cancer—Factors Affecting Diagnostic Success. Radiology. 269(3). 816–823. 47 indexed citations
15.
Spritzer, Charles E., P. Diana Afonso, Emily N. Vinson, et al.. (2013). Bone Marrow Biopsy: RNA Isolation with Expression Profiling in Men with Metastatic Castration-resistant Prostate Cancer—Factors Affecting Diagnostic Success. Radiology. 121782–121782. 2 indexed citations
16.
Turnbull, James, Julien Cobert, Tracy A. Jaffe, et al.. (2012). Activity of Single-Agent Bevacizumab in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors. Clinical Genitourinary Cancer. 11(1). 45–50. 12 indexed citations
17.
Armstrong, Andrew J., Matthew S. Marengo, Sebastian Oltean, et al.. (2011). Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers. Molecular Cancer Research. 9(8). 997–1007. 536 indexed citations breakdown →
18.
Armstrong, Andrew J., Patricia Creel, James Turnbull, et al.. (2008). A Phase I-II Study of Docetaxel and Atrasentan in Men with Castration-Resistant Metastatic Prostate Cancer. Clinical Cancer Research. 14(19). 6270–6276. 52 indexed citations
19.
Molloy, D. William, et al.. (2007). Effects of Acute Exposure to Aluminum on Cognition in Humans. Journal of Toxicology and Environmental Health. 70(23). 2011–2019. 20 indexed citations
20.
Fletcher, Glenn G., et al.. (1994). Toxicity, uptake, and mutagenicity of particulate and soluble nickel compounds.. Environmental Health Perspectives. 102(suppl 3). 69–79. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joan Bolt‐de Vries Breakdown of academic impact, for papers by Zhangjun Cheng Breakdown of academic impact, for papers by Daniel C. Christoph Breakdown of academic impact, for papers by Hongjun Gao Breakdown of academic impact, for papers by Kara Hamilton Breakdown of academic impact, for papers by Sun Young Lee Breakdown of academic impact, for papers by Carla Cavaliere Breakdown of academic impact, for papers by Jeremy McGuire Breakdown of academic impact, for papers by R E Durand Breakdown of academic impact, for papers by Yongfu Ma
Rankless by CCL
2026